Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation

Suzuki Fujio Suzuki, Matsumoto Kaori Matsumoto, David A. Schmitt, Richard B. Pollard, Maeda Hiroshi

Research output: Contribution to journalArticle

3 Scopus citations


Immunomodulatory effects of oily formulated SMANCS, a polymer conjugated derivative of the proteinsceous antibiotic neocarzinostatin, after oral administrations to mice was investigated. The oral administrations of SMANCS, dissolved in medium-chain triglyceride containing phosphatidylcholine and polyglycerine dioleate (oily SMANCS), resulted in: (1) augmentation of NK cell activity in naive mice, (2) activation of macrophage cytostasis in naive mice, (3) enhancement of the generation of cytotoxic T-lymphocytes in mice immunized with allogeneic lymphocytes, (4) production of circulating interferon in naive mice, and (5) increase of delayed-type hypersensitivity response in mice immunized with sheep red blood cells. The degree of immunomodulation orally stimulated with oily SMANCS was similar to that of the immunomodulation induced by i.v. or i.p. administrations of aqueous formulated SMANCS (aqueous SMANCS). Although SMANCS is a protein drug that may be digestable by various enzymes present in the stomach, in the present study immunomodulating activities of SMANCS were clearly demonstrated when an oily formulation of the compound was administered to mice orally. Since aqueous SMANCS administered parenterally and oily SMANCS administered orally exhibit the same immunomodulatory activities and the former has demonstrated antitumor activity in man and animals, the latter may possess this same antitumor activity.

Original languageEnglish (US)
Pages (from-to)175-183
Number of pages9
JournalInternational Journal of Immunopharmacology
Issue number2
StatePublished - Feb 1993


ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this